Valicare extends GxP expertise

▴ Valicare extends GxP expertise
A new focus is on consulting services for the transition of products from the development phase to the GMP compliant manufacturing of investigational medicinal products

Valicare GmbH, a wholly owned subsidiary of Syntegon, now offers additional services along the entire product life cycle of pharmaceutically and biotechnologically produced drugs. A new focus is on consulting services for the transition of products from the development phase to the GMP compliant manufacturing of investigational medicinal products.These services are complemented by the presentation and assessment of market-specific requirements, investigational drug management and the necessary regulatory interactions.

To underline the extension of the service portfolio, Valicare has recruited Dr Christin Erbach to join the expert team of engineers and scientists as a Senior GMP Consultant. Dr Erbach has more than ten years of clinical service experience along with deep knowledge in quality management and legal pharmaceutical requirements. She also successfully supported pharmaceutical businesses during their establishment phase.

“Her specialized knowledge in the area of clinical services combined with her legal background is an outstanding addition to Valicare’s consultancy business,” says Dr Hans-Georg Eckert, site manager of Valicare in Frankfurt. “She will strengthen our competenciesregarding the first GMP steps and the legal requirements for clinical products, addressing special needs for each development stage. This way, we are able to extend our approach of accompanying products along their complete life cycle.”

Valicare is significantly expanding its GxP and consultancy services for the pharma, biotech and ATMP industries to fulfill individual demands regarding products and projects from development to market release. As far as ATMPs are concerned, the company already supports customers in meeting regulatory requirements for more and more individual therapies and minimizing associated risks.Valicare also offers complete solutions for the production of ATMPs as well as consulting and supporting services, right through to the production of the first investigational medicinal products.

Valicare GmbH has been a GMP consulting service provider with headquarter in Frankfurt/Main, Germany, since 2002. More than 100 natural scientists and engineers support the pharma, biotech and medical technology industry with a broad portfolio of GxP services. Valicare is a subsidiary of Syntegon, a global supplier of process and packaging technology for the pharmaceutical and food industries, Valicare is a renowned expert for GxP compliance support with a special focus on aseptic filling processes and ATMP manufacturing. More than 1,500 GMP projects make Valicare an expert in this field.

Tags : #ValicareGmbH #Syntegon #LatestPharmaNews22ndOct #DrChristinErbach #Germany #DrHansGeorgEckert

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

China Doctors Remove Live Worms from Woman’s Eyes HealthCare December 11, 2023
Immunity Boosting Measures for Optimal Health during WinterDecember 11, 2023
How to Save Gaza’ Catastrophic For HealthCareDecember 11, 2023
Broccoli Important For Our Health December 11, 2023
Seminar on RERA: Concerns in Real Estate heldDecember 09, 2023
Commonwealth youth leaders want action, not just rhetoric at COP28December 09, 2023
South India’s biggest Gaushala, Satyam Shivam Sundaram Gau Nivas to conduct Annakut Celebrations on Sunday on the eve of its 23rd AnniversaryDecember 08, 2023
Center for Diagnostics and Telemedicine Introduces Groundbreaking Service – Preliminary Clinical and Technical Testing for Medical SoftwareDecember 08, 2023
FTCCI to hold a Seminar on RERA: Concerns in Real EstateDecember 08, 2023
Adoption of Public Health Strategies and Early Detection Key for Cancer Mitigation: ExpertsDecember 08, 2023
Are online spaces safe for women?December 08, 2023
Prescribing Equality: Tackling Gender Disparities in India's Healthcare LeadershipDecember 07, 2023
Digitalizing Health: Generative AI's Impact Amplified by AWS Cloud in IndiaDecember 07, 2023
Eyes on the Future: Dr. Agarwal's Group Channels Rs 100 Crore for Cutting-edge Eye Hospitals Across KeralaDecember 06, 2023
Organ Transplant Scandal: Apollo Hospital Faces Government InquiryDecember 06, 2023
Breaking Barriers in Cancer Treatment: Max Healthcare's CAR-T Therapy PartnershipDecember 06, 2023
Exploring the Link Between Covid-19 Vaccination and Sudden Cardiac Arrests: ICMR StudyNovember 22, 2023
Powering the Future: China's Biodegradable Wireless System for Bioelectronic InnovationNovember 22, 2023
IMS BHU Pioneers Advanced Cardiac Care: Unveiling Cutting-Edge Technologies for Precise DiagnosisNovember 18, 2023
Inito's $6 Million Boost: Transforming Women's Health with AI-Backed Fertility MonitoringNovember 18, 2023